Literature DB >> 31010609

Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon.

Kazuhisa Furue1, Takamichi Ito1, Yuka Tanaka1, Ayako Yumine1, Akiko Hashimoto-Hachiya1, Masaki Takemura1, Maho Murata1, Kazuhiko Yamamura1, Gaku Tsuji1, Masutaka Furue2.   

Abstract

BACKGROUND: Scratch injury induces Koebner phenomenon in psoriasis. Smoking is also a risk factor for psoriasis. Keratinocytes can produce various psoriasis-related molecules including TNF, IL1 A, IL1B, IL6, IL12B, IL17C, IL23 A, IL36 A, IL36B, IL36 G, CXCL1, CXCL2, CXCL8, CXCL9, CXCL10, CCL20, IFNB, and CAMP. However, the scratch-induced molecular profiling remains elusive.
OBJECTIVE: To profile the induction pattern of above-mentioned psoriasis-related and keratinocyte-derived molecules by scratch injury in the presence or absence of anti-psoriatic drugs or benzo[a]pyrene, a major environmental pollutant of tobacco smoke.
METHODS: Confluent normal human keratinocytes were scratched and molecules were assayed by qRT-PCR, ELISA and Western blotting with or without drugs and benzo[a]pyrene.
RESULTS: Among the 18 molecules, the scratch injury on a confluent keratinocyte sheet significantly and selectively upregulated the mRNA expression of four cyto/chemokines, CXCL8, CCL20, IL36G, and TNF, in a scratch-line-number-dependent manner under either low- or high-calcium condition. However, significant protein secretion was only demonstrated for CXCL8 and CCL20. The IL36 G protein was not secreted, but its intracellular level was significantly upregulated by scratch injury, whereas neither the secretion nor the intracellular level of TNF protein was affected by scratch injury. Dexamethasone, but not maxacalcitol nor the phosphodiesterase 4 inhibitor apremilast, partially inhibited the CXCL8 and CCL20 secretion. Benzo[a]pyrene significantly and synergistically enhanced the scratch-induced CCL20 secretion that may explain why smoking is a risk factor for psoriasis.
CONCLUSION: CCL20 and to a less extent CXCL8 may play a key role in triggering the Koebner phenomenon after scratch injury to keratinocytes.
Copyright © 2019 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CCL20; CXCL8; Koebner phenomenon; Psoriasis; Smoking

Year:  2019        PMID: 31010609     DOI: 10.1016/j.jdermsci.2019.04.002

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  11 in total

1.  Transcriptomic Profiling of Peripheral Edge of Lesions to Elucidate the Pathogenesis of Psoriasis Vulgaris.

Authors:  Suphagan Boonpethkaew; Jitlada Meephansan; Onjira Jumlongpim; Pattarin Tangtanatakul; Wipasiri Soonthornchai; Jongkonnee Wongpiyabovorn; Ratchanee Vipanurat; Mayumi Komine
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

2.  The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients.

Authors:  Kazuhisa Furue; Takamichi Ito; Yuka Tanaka; Akiko Hashimoto-Hachiya; Masaki Takemura; Maho Murata; Makiko Kido-Nakahara; Gaku Tsuji; Takeshi Nakahara; Masutaka Furue
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

3.  Phellodendron amurense Extract Protects Human Keratinocytes from PM2.5-Induced Inflammation via PAR-2 Signaling.

Authors:  Jiyoung Choi; Mi Yeon Moon; Gi Yeon Han; Moon Sik Chang; Dongki Yang; Joonseok Cha
Journal:  Biomolecules       Date:  2020-12-28

4.  Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice.

Authors:  Lifang Wen; Xiaoru Dong; Qing Li; Gabriele Schramm; Bing Zhang; Detlef Zillikens; Ralf J Ludwig; Frank Petersen; Xinhua Yu
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

5.  Enhanced Fluctuations in Facial Pore Size, Redness, and TEWL Caused by Mask Usage Are Normalized by the Application of a Moisturizer.

Authors:  Kukizo Miyamoto; Yoko Munakata; Xianghong Yan; Gaku Tsuji; Masutaka Furue
Journal:  J Clin Med       Date:  2022-04-11       Impact factor: 4.964

6.  Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study.

Authors:  Paolo Gisondi; Francesco Bellinato; Giampiero Girolomoni
Journal:  Vaccines (Basel)       Date:  2022-07-23

7.  A Modified Hyaluronic Acid-Based Dissolving Microneedle Loaded With Daphnetin Improved the Treatment of Psoriasis.

Authors:  Shiya Peng; Liuhanghang Cheng; Qian Wu; Yuanchao Li; Lei Ran; Wei Wang; Ke Huang; Rong Zhu; Sihong Xue; Chunli Zhou; Weidong Zhu; Biao Cheng; Xiaobing Fu; Rupeng Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-17

Review 8.  The biological basis of disease recurrence in psoriasis: a historical perspective and current models.

Authors:  Lluís Puig; Antonio Costanzo; Ernesto J Muñoz-Elías; Maria Jazra; Sven Wegner; Carle F Paul; Curdin Conrad
Journal:  Br J Dermatol       Date:  2022-05       Impact factor: 11.113

Review 9.  Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms.

Authors:  Yong-Zhi Ji; Shi-Rui Liu
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

10.  Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice.

Authors:  Fei Li; Dan Han; Bo Wang; Wentao Zhang; Yan Zhao; Jing Xu; Liesu Meng; Kuanhou Mou; Shemin Lu; Wenhua Zhu; Yan Zhou
Journal:  Mediators Inflamm       Date:  2022-01-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.